Gilead Sciences to start clinical trials of inhaled remdesivir for COVID-19

Gilead Sciences plans to start clinical trials for an inhaled version of the antiviral remdesivir for the treatment of COVID-19, company officials said Monday.
Source: Health News - UPI.com - Category: Consumer Health News Source Type: news